Akari Therapeutics Plc (AKTX)
8.76
-0.53
(-5.71%)
USD |
NASDAQ |
Oct 21, 16:00
9.00
+0.24
(+2.74%)
After-Hours: 20:00
Akari Therapeutics Net Income (Annual) : -17.34M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -17.34M |
| December 31, 2024 | -19.80M |
| December 31, 2023 | -10.01M |
| December 31, 2022 | -17.75M |
| December 31, 2021 | -17.42M |
| December 31, 2020 | -17.08M |
| December 31, 2019 | -16.92M |
| December 31, 2018 | -16.47M |
| Date | Value |
|---|---|
| December 31, 2017 | -35.40M |
| December 31, 2016 | -18.06M |
| December 31, 2015 | -45.31M |
| December 31, 2014 | -9.609M |
| December 31, 2013 | -3.62M |
| December 31, 2012 | -4.254M |
| December 31, 2011 | -2.116M |
| December 31, 2010 | -0.6759M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| DBV Technologies SA | -147.40M |
| Cellectis SA | -67.80M |
| Bicycle Therapeutics Plc | -219.47M |
| argenx SE | 1.296B |
| Autolus Therapeutics Plc | -288.20M |